Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$3.10 USD
+0.11 (3.68%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/03/2024
Time: -- |
3/2024 | $-0.22 | 23.60% |
Earnings Summary
For their last quarter, Ovid Therapeutics (OVID) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.17 per share. This reflects a negative earnings surprise of 29.41%. Look out for OVID's next earnings release expected on May 03, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year decrease of 15.79%.
Earnings History
Price & Consensus
Zacks News for OVID
Poseida Therapeutics, Inc. (PSTX) Reports Q4 Loss, Tops Revenue Estimates
OVID: What are Zacks experts saying now?
Zacks Private Portfolio Services